34.4 Potassium-Sparing Diuretics

Potassium-Sparing Diuretics

Potassium-sparing diuretics help manage fluid balance and blood pressure while preserving the body's potassium stores. Most other diuretics (loop diuretics, thiazides) cause potassium loss as a side effect, which can lead to dangerous hypokalemia. Potassium-sparing agents solve this problem by blocking sodium reabsorption in ways that don't trigger potassium excretion.

These drugs fall into two categories based on how they work: aldosterone antagonists (spironolactone, eplerenone) and epithelial sodium channel (ENaC) blockers (amiloride, triamterene). Understanding which category a drug belongs to helps you predict its side effects and drug interactions.

Mechanism of Action and Primary Uses

Potassium-sparing diuretics act on the distal tubule and collecting duct of the nephron. In this part of the kidney, aldosterone normally promotes sodium reabsorption and potassium secretion. These drugs interrupt that process through two distinct mechanisms:

• Aldosterone antagonists (spironolactone, eplerenone) competitively block aldosterone from binding to its receptor. Without aldosterone signaling, the cells reabsorb less sodium and secrete less potassium.
• ENaC blockers (amiloride, triamterene) directly block the epithelial sodium channels on the luminal side of the tubule. Sodium stays in the tubular fluid, and because less sodium enters the cell, the sodium-potassium exchange slows down, so less potassium is lost.

Both mechanisms produce the same net result: more sodium and water leave the body in urine (natriuresis and diuresis), while potassium is retained.

Primary clinical uses:

• Edema and hypertension from fluid volume excess
• Heart failure, particularly spironolactone and eplerenone, which have mortality benefits in HF patients
• Hyperaldosteronism (primary or secondary), where excess aldosterone drives sodium retention
• Prevention of hypokalemia when combined with loop diuretics or thiazides that cause potassium wasting
• Renal disorders such as nephrotic syndrome, to reduce fluid overload

These are considered mild diuretics on their own. They're most often used in combination with stronger diuretics rather than as standalone therapy.

Common Potassium-Sparing Diuretics

Spironolactone (Aldactone)

Spironolactone is an aldosterone antagonist used for edema, hypertension, heart failure, and hyperaldosteronism. It blocks aldosterone receptors in the distal tubule and collecting duct, increasing sodium and water excretion while reducing potassium loss.

• A key concern is its nonselective receptor binding. Spironolactone also binds to androgen and progesterone receptors, which causes endocrine side effects: gynecomastia (breast tissue enlargement in males), breast tenderness, and menstrual irregularities in females.
• Risk of hyperkalemia, especially in patients with renal impairment or those taking other potassium-elevating drugs.

Eplerenone (Inspra)

Eplerenone is a newer aldosterone antagonist with the same indications as spironolactone for heart failure and hypertension. The major advantage is its higher selectivity for the aldosterone receptor, meaning it has a much lower incidence of gynecomastia and menstrual irregularities.

• Still carries risk of hyperkalemia, dizziness, and fatigue.
• Often preferred over spironolactone when endocrine side effects are a concern.

Amiloride (Midamor)

Amiloride is an ENaC blocker that directly blocks sodium channels in the distal tubule and collecting duct. It's frequently combined with thiazides or loop diuretics to offset their potassium-wasting effects.

• Used for edema and hypertension, usually as add-on therapy rather than monotherapy.
• Side effects include hyperkalemia, nausea, diarrhea, and headache.

Triamterene (Dyrenium)

Triamterene works by the same ENaC-blocking mechanism as amiloride and has similar indications. It's commonly found in combination products (e.g., triamterene/hydrochlorothiazide).

• Side effects include hyperkalemia, nausea, vomiting, dizziness, and photosensitivity (increased skin sensitivity to sunlight). Patients should be advised to use sunscreen and protective clothing.

Nursing Considerations

Monitoring

• Measure intake and output (I&O) to track fluid balance and catch early signs of dehydration or fluid overload.
• Check serum electrolytes regularly, especially potassium and sodium. Normal serum potassium is 3.5–5.0 mEq/L. Values above 5.0 mEq/L signal hyperkalemia.
• Monitor blood pressure and daily weight to evaluate therapeutic effectiveness. A sudden weight gain may indicate fluid retention; rapid loss may signal excessive diuresis.
• Watch for signs of hyperkalemia: muscle weakness, fatigue, paresthesias (tingling), and most critically, cardiac dysrhythmias (irregular heartbeat, peaked T waves on ECG). Hyperkalemia can be life-threatening.

Safety Precautions

• Use with extra caution in renal impairment. Reduced kidney function means the body can't excrete potassium efficiently, significantly raising hyperkalemia risk.
• Avoid combining with other drugs that raise potassium levels: ACE inhibitors (e.g., lisinopril), ARBs (e.g., losartan), potassium supplements, and other potassium-sparing diuretics. If combination therapy is necessary, potassium levels need very close monitoring.
• Dosage adjustments should be based on renal function (GFR/creatinine) and serum potassium levels.
• Ensure patients understand the importance of follow-up lab work. Potassium can rise gradually and become dangerous without symptoms.

Patient Education Plan

Medication Administration

• Take the medication at the same time each day for a consistent effect. Taking it in the morning or early afternoon can help avoid nighttime trips to the bathroom.
• Never stop the medication abruptly without consulting the prescriber. Stopping suddenly can cause rebound fluid retention or blood pressure spikes.

Dietary Considerations

This is one of the most important teaching points for potassium-sparing diuretics. Unlike patients on loop diuretics or thiazides (who often need to increase potassium intake), patients on these drugs need to avoid excess potassium.

• Eat a balanced diet with moderate potassium intake. There's no need to eliminate potassium-rich foods entirely, but large quantities should be avoided.
• High-potassium foods to consume in moderation: bananas, oranges, potatoes, tomatoes, spinach, and avocados.
• Avoid salt substitutes that contain potassium chloride (KCl). Many patients don't realize these products can significantly spike potassium levels.

Self-Monitoring

• Weigh yourself daily at the same time, wearing similar clothing. Report a gain of $>$ 2 lbs in one day or $>$ 5 lbs in one week to the healthcare provider.
• Know the warning signs of electrolyte imbalance: muscle cramps, weakness, irregular heartbeat, numbness or tingling. Report these promptly.
• Keep all follow-up appointments and complete scheduled lab work. Potassium levels can shift without obvious symptoms.

Lifestyle Modifications

• Regular physical activity (aim for 30 minutes most days of the week) and stress management support blood pressure control alongside medication therapy.
• Limit alcohol intake ($\leq$ 1 drink/day for women, $\leq$ 2 drinks/day for men) and avoid smoking to reduce cardiovascular risk and improve drug effectiveness.
• For patients taking triamterene, apply sunscreen and wear protective clothing due to photosensitivity risk.